SynthesisReviews in medical virology2021
Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.
Synthesis in Reviews in medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Patient and Staff Experience of Remote Patient Monitoring-What to Measure and How: Systematic Review.Journal of medical Internet research · 2024Pooled it
- Pooled it
- Prevalence of oral manifestations in COVID-19: A systematic review.Reviews in medical virology · 2022Pooled it
- Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis.Reviews in medical virology · 2022Pooled it
- Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.Reviews in medical virology · 2021Pooled it
- Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis.The Lancet. Global health · 2021Pooled it
- Factors Influencing the Maintenance of Public Health Behaviors After an Epidemic: Cross-Sectional Study.JMIR public health and surveillance · 2025Article
- People's Attitude and Perception of the Pandemic on Twitter: A Case Study of COVID-19 in India.Cureus · 2024Article
- Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru.Global epidemiology · 2024Article
- Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.Proceedings of the National Academy of Sciences of the United States of America · 2024Article
- Is the surge in cesarean section rates during the COVID-19 pandemic truly substantiated?BMC pregnancy and childbirth · 2024Article
- Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey.Proceedings. Biological sciences · 2023Article
- Vitamin D status and blood group among severe COVID-19 patients.Annals of medicine and surgery (2012) · 2023Article
- Article
- An assessment of the relationship between national rates of Covid-19 incidence and mortality as reported to an international comparison database: An ecological study.Health science reports · 2023Article
- Article
- Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic.PloS one · 2023Article
- LiteCovidNet: A lightweight deep neural network model for detection of COVID-19 using X-ray images.International journal of imaging systems and technology · 2022Article
- An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalence.Nature communications · 2022Article
- Real-World Effectiveness of the mRNA COVID-19 Vaccines in Japan: A Case-Control Study.Vaccines · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular and/or serological tests to estimate the prevalence of Covid-19 in the general population. Survey quality was assessed using the Joanna Briggs Institute Critical Appraisal Checklist for Prevalence Studies. A correspondence analysis correlated methodological parameters of each study to identify patterns related to higher, intermediate and lower risks of bias. The available data described 37 surveys from 19 countries. The majority were from Europe and America, used antibody testing, and reached highly heterogeneous sample sizes and prevalence estimates. Minority communities were disproportionately affected by Covid-19. Important risk of bias was detected in four domains: sample size, data analysis with sufficient coverage, measurements in standard way and response rate. The correspondence analysis showed few consistent patterns for high risk of bias. Intermediate risk of bias was related to American and European studies, municipal and regional initiatives, blood samples and prevalence >1%. Low risk of bias was related to Asian studies, nationwide initiatives, reverse-transcriptase polymerase chain reaction tests and prevalence <1%. We identified methodological standards applied worldwide in Covid-19 prevalence surveys, which may assist researchers with the planning, execution and reporting of future population-based surveys.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.